-
1
-
-
14944386870
-
Evaluation and management of non-alcoholic steatohepatitis
-
DOI 10.1016/j.jhep.2004.11.022, Management of Liver Diseases 2005
-
Ramesh S, Sanyal AJ. Evaluation and management of non-alcoholic steatohepatitis. J Hepatol 2005; 42 (Suppl 1):S2-S12. (Pubitemid 40364599)
-
(2005)
Journal of Hepatology
, vol.42
, Issue.SUPPL. 1
-
-
Ramesh, S.1
Sanyal, A.J.2
-
2
-
-
75449088414
-
Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
-
Soderberg C, Stal P, Askling J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010; 51:595-602.
-
(2010)
Hepatology
, vol.51
, pp. 595-602
-
-
Soderberg, C.1
Stal, P.2
Askling, J.3
-
3
-
-
0025039064
-
Biochemical changes and morphological alterations of the liver in guinea-pigs after administration of simvastatin (HMG CoA reductase-inhibitor)
-
Horsman Y, Desager JP, Harvengt C. Biochemical changes and morphological alterations of the liver in guinea-pigs after administration of simvastatin. Pharmacol Toxicol 1990; 67:336-339. (Pubitemid 20358741)
-
(1990)
Pharmacology and Toxicology
, vol.67
, Issue.4
, pp. 336-339
-
-
Horsmans, Y.1
Desager, J.-P.2
Harvengt, C.3
-
5
-
-
4544363071
-
Liver transplantation for acute liver failure from drug induced liver injury in the United States
-
DOI 10.1002/lt.20204
-
Russo MW, Galanko JA, Shrestha R, et al. Liver transplantation from drug induced liver injury in the United States. Liver Transpl 2004; 10:1018-1023. (Pubitemid 39232756)
-
(2004)
Liver Transplantation
, vol.10
, Issue.8
, pp. 1018-1023
-
-
Russo, M.W.1
Galanko, J.A.2
Shrestha, R.3
Fried, M.W.4
Watkins, P.5
-
6
-
-
57249086242
-
Causes, clinical features, and outcomes from a prospective study of drug induced liver injury in the United States
-
Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug induced liver injury in the United States. Gastroenterology 2008; 135:1924-1934; 1934 e1-1934 e4.
-
(2008)
Gastroenterology
, vol.135
-
-
Chalasani, N.1
Fontana, R.J.2
Bonkovsky, H.L.3
-
7
-
-
18744376412
-
Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period
-
DOI 10.1016/j.gastro.2005.05.006, PII S0016508505008760
-
Andrade RJ, Lucena IM, Fernandez C, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish Registry over a 10-year period. Gastroenterology 2005; 129:512-521. (Pubitemid 41096639)
-
(2005)
Gastroenterology
, vol.129
, Issue.2
, pp. 512-521
-
-
Andrade, R.J.1
Lucena, M.I.2
Fernandez, M.C.3
Pelaez, G.4
Pachkoria, K.5
Garcia-Ruiz, E.6
Garcia-Munoz, B.7
Gonzalez-Grande, R.8
Pizarro, A.9
Duran, J.A.10
Jimenez, M.11
Rodrigo, L.12
Romero-Gomez, M.13
Navarro, J.M.14
Planas, R.15
Costa, J.16
Borras, A.17
Soler, A.18
Salmeron, J.19
Martin-Vivaldi, R.20
more..
-
8
-
-
78649890465
-
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: A post-hoc analysis
-
Excellent post-hoc analysis from randomized trial of safety of statins (mostly atorvastatin) in patients with elevated baseline liver tests up to three times upper limit of normal
-
Athyros VG, Tziomalos K, Gossios TD, et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 2010; 376:1916-1922. Excellent post-hoc analysis from randomized trial of safety of statins (mostly atorvastatin) in patients with elevated baseline liver tests up to three times upper limit of normal.
-
(2010)
Lancet
, vol.376
, pp. 1916-1922
-
-
Athyros, V.G.1
Tziomalos, K.2
Gossios, T.D.3
-
9
-
-
78650457786
-
Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C
-
Retrospective study demonstrating higher response rates to antiviral therapy among diabetic patients who were on statins during treatment with interferon and ribavirin
-
Rao GA, Pandya PK. Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C. Gastroenterology 2011; 140:144-152. Retrospective study demonstrating higher response rates to antiviral therapy among diabetic patients who were on statins during treatment with interferon and ribavirin.
-
(2011)
Gastroenterology
, vol.140
, pp. 144-152
-
-
Rao, G.A.1
Pandya, P.K.2
-
10
-
-
74049088561
-
Statin therapy and serum transaminases among a cohort of HCV-infected veterans
-
Henderson LM, Patel S, Giordano TP, et al. Statin therapy and serum transaminases among a cohort of HCV-infected veterans. Dig Dis Sci 2010; 55:190-195.
-
(2010)
Dig Dis Sci
, vol.55
, pp. 190-195
-
-
Henderson, L.M.1
Patel, S.2
Giordano, T.P.3
-
11
-
-
77953696964
-
Individualizing the risks of statins in men and women in England and Wales: Population-based cohort study
-
Hippisley-Cox J, Coupland C. Individualizing the risks of statins in men and women in England and Wales: population-based cohort study. Heart 2010; 96:939-947.
-
(2010)
Heart
, vol.96
, pp. 939-947
-
-
Hippisley-Cox, J.1
Coupland, C.2
-
12
-
-
36348987648
-
Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial
-
DOI 10.1002/hep.21848
-
Lewis JH, Mortensen ME, Zweig S, et al. Efficacy and safety of highdose pravastatin in hypercholesterolemic patients with well compensated chronic liver disease: results of a prospective, randomized, doubleblind, placebo-controlled, multicenter trial. Hepatology 2007; 46:1453-1463. (Pubitemid 350155527)
-
(2007)
Hepatology
, vol.46
, Issue.5
, pp. 1453-1463
-
-
Lewis, J.H.1
Mortensen, M.E.2
Zweig, S.3
Fusco, M.J.4
Medoff, J.R.5
Belder, R.6
-
13
-
-
34249342305
-
Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: A histopathological follow-up study>
-
DOI 10.1016/j.jhep.2007.02.013, PII S0168827807001298
-
Ekstedt M, Franzen LE, Mathiesen UL, et al. Statins in nonalcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological followup study. J Hepatol 2007; 47:135-141. (Pubitemid 46817693)
-
(2007)
Journal of Hepatology
, vol.47
, Issue.1
, pp. 135-141
-
-
Ekstedt, M.1
Franzen, L.E.2
Mathiesen, U.L.3
Holmqvist, M.4
Bodemar, G.5
Kechagias, S.6
-
14
-
-
0346103657
-
Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation
-
DOI 10.1073/pnas.2237238100
-
Ye J, Wang C, Sumpter R Jr, et al. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc Natl Acad Sci U S A 2003; 100:15865-15870. (Pubitemid 38021081)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.26
, pp. 15865-15870
-
-
Ye, J.1
Wang, C.2
Sumpter Jr., R.3
Brown, M.S.4
Goldstein, J.L.5
Gale Jr., M.6
-
15
-
-
77956646681
-
Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy
-
Harrison SA, Rossaro L, Hu K, et al. Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy. Hepatology 2010; 52:864-874.
-
(2010)
Hepatology
, vol.52
, pp. 864-874
-
-
Harrison, S.A.1
Rossaro, L.2
Hu, K.3
-
16
-
-
65349094504
-
Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: A randomized controlled trial
-
Provocative article suggesting statins may reduce portal hypertension in cirrhotics and lower the risk of variceal hemorrhage
-
Abraldes JG, Albillos A, Banares R, et al. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology 2009; 136:1651-1658. Provocative article suggesting statins may reduce portal hypertension in cirrhotics and lower the risk of variceal hemorrhage.
-
(2009)
Gastroenterology
, vol.136
, pp. 1651-1658
-
-
Abraldes, J.G.1
Albillos, A.2
Banares, R.3
-
17
-
-
65249190240
-
Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes
-
El-Serag HB, Johnson ML, Hachem C, Morgana RO. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology 2009; 136:1601-1608.
-
(2009)
Gastroenterology
, vol.136
, pp. 1601-1608
-
-
El-Serag, H.B.1
Johnson, M.L.2
Hachem, C.3
Morgana, R.O.4
-
18
-
-
33645888317
-
National Lipid Association Statin Safety Task Force Liver Expert Panel: An assessment of statin safety by hepatologists
-
Cohen DE, Anania FA, Chalasani N. National Lipid Association Statin Safety Task Force Liver Expert Panel: an assessment of statin safety by hepatologists. Am J Cardiol 2006; 97:77C-81C.
-
(2006)
Am J Cardiol
, vol.97
-
-
Cohen, D.E.1
Anania, F.A.2
Chalasani, N.3
|